Ross A. McKinnon

8.7k total citations · 1 hit paper
224 papers, 6.3k citations indexed

About

Ross A. McKinnon is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Ross A. McKinnon has authored 224 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Biology, 70 papers in Oncology and 69 papers in Pharmacology. Recurrent topics in Ross A. McKinnon's work include Pharmacogenetics and Drug Metabolism (66 papers), Drug Transport and Resistance Mechanisms (28 papers) and Computational Drug Discovery Methods (14 papers). Ross A. McKinnon is often cited by papers focused on Pharmacogenetics and Drug Metabolism (66 papers), Drug Transport and Resistance Mechanisms (28 papers) and Computational Drug Discovery Methods (14 papers). Ross A. McKinnon collaborates with scholars based in Australia, United States and United Kingdom. Ross A. McKinnon's co-authors include Michael J. Sorich, John O. Miners, Peter I. Mackenzie, Andrew Rowland, Ganessan Kichenadasse, Michael D. Wiese, Daniel W. Nebert, Robyn Meech, Christos S. Karapetis and Dong Hu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Ross A. McKinnon

215 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials

2014 383 citations Michael J. Sorich, Michael D. Wiese et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ross A. McKinnon Australia	44	2.3k	2.0k	1.8k	858	577	224	6.3k
Shu‐Feng Zhou China	55	4.1k 1.8×	2.1k 1.1×	2.8k 1.6×	771 0.9×	666 1.2×	340	11.7k
Cristina Rodríguez‐Antona Spain	39	2.2k 0.9×	2.1k 1.0×	2.0k 1.1×	1.1k 1.3×	767 1.3×	137	6.0k
Marilyn E. Morris United States	45	3.4k 1.5×	2.2k 1.1×	1.1k 0.6×	704 0.8×	361 0.6×	189	7.8k
Jürgen Borlak Germany	49	3.8k 1.6×	1.0k 0.5×	1.6k 0.9×	1.4k 1.6×	496 0.9×	201	8.7k
Hong‐Hao Zhou China	49	3.6k 1.5×	1.4k 0.7×	1.7k 0.9×	1.5k 1.8×	656 1.1×	258	7.8k
Wei Zhang China	44	3.1k 1.3×	1.3k 0.6×	993 0.6×	1.4k 1.6×	496 0.9×	351	7.0k
Caroline F. Thorn United States	35	2.2k 0.9×	1.3k 0.6×	2.0k 1.2×	445 0.5×	375 0.6×	58	6.9k
Michael J. Sorich Australia	38	1.8k 0.8×	2.1k 1.0×	779 0.4×	480 0.6×	813 1.4×	205	5.7k
Ute Hofmann Germany	45	1.7k 0.7×	1.9k 0.9×	1.6k 0.9×	549 0.6×	315 0.5×	183	6.3k
Jukka Hakkola Finland	44	1.6k 0.7×	1.1k 0.5×	2.1k 1.2×	597 0.7×	284 0.5×	93	5.2k

Countries citing papers authored by Ross A. McKinnon

Since Specialization

Citations

This map shows the geographic impact of Ross A. McKinnon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross A. McKinnon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross A. McKinnon more than expected).

Fields of papers citing papers by Ross A. McKinnon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross A. McKinnon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross A. McKinnon. The network helps show where Ross A. McKinnon may publish in the future.

Co-authorship network of co-authors of Ross A. McKinnon

This figure shows the co-authorship network connecting the top 25 collaborators of Ross A. McKinnon. A scholar is included among the top collaborators of Ross A. McKinnon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross A. McKinnon. Ross A. McKinnon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Modi, Natansh D., Ahmad Y. Abuhelwa, Nicole M. Kuderer, et al.. (2025). Associations of Commonly Used Concomitant Medications With Survival and Adverse Event Outcomes in Breast Cancer. Cancer Medicine. 14(21). e71320–e71320.

Abuhelwa, Ahmad Y., Ethan Basch, Humaid O. Al‐Shamsi, et al.. (2025). Predictive and Prognostic Significance of Patient‐Reported Outcomes for Survival and Adverse Events in Daratumumab‐Treated Multiple Myeloma. European Journal Of Haematology. 114(6). 1020–1031.

Abuhelwa, Ahmad Y., Jennifer R. Brown, Humaid O. Al‐Shamsi, et al.. (2025). Statin use and survival in CLL/SLL treated with ibrutinib: pooled analysis of 4 randomized controlled trials. Blood Advances. 9(14). 3566–3575. 1 indexed citations

Mashtoub, Suzanne, Shahid Ullah, Gurmeet Singh, et al.. (2024). Childhood Cancer Incidence and Survival in South Australia and the Northern Territory, 1990–2017, with Emphasis on Indigenous Peoples. Cancers. 16(11). 2057–2057.

Orang, Ayla, Shashikanth Marri, Ross A. McKinnon, Janni Petersen, & Michael Michael. (2024). Restricting Colorectal Cancer Cell Metabolism with Metformin: An Integrated Transcriptomics Study. Cancers. 16(11). 2055–2055. 3 indexed citations

Alqudah, Mohammad A. Y., Ziad Abuhelwa, Humaid O. Al‐Shamsi, et al.. (2024). Antithrombotic utilization, adverse events, and associations with treatment outcomes in multiple myeloma: pooled analysis of three clinical trials. Therapeutic Advances in Medical Oncology. 16. 12720123–12720123.

Hopkins, Ashley M., Natansh D. Modi, Ahmad Y. Abuhelwa, et al.. (2023). Heterogeneity and Utility of Pharmaceutical Company Sharing of Individual-Participant Data Packages. JAMA Oncology. 9(12). 1621–1621. 11 indexed citations

Hu, Dong, Shashikanth Marri, Julie-Ann Hulin, et al.. (2022). The Somatic Mutation Landscape of UDP-Glycosyltransferase (UGT) Genes in Human Cancers. Cancers. 14(22). 5708–5708. 5 indexed citations

Hopkins, Ashley M., Ganessan Kichenadasse, Ross A. McKinnon, et al.. (2021). Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150. British Journal of Cancer. 126(1). 42–47. 51 indexed citations

10.

Orang, Ayla, et al.. (2021). Integrative Transcriptomic Network Analysis of Butyrate Treated Colorectal Cancer Cells. Cancers. 13(4). 636–636. 15 indexed citations

11.

Hopkins, Ashley M., Ahmad Y. Abuhelwa, Ross A. McKinnon, et al.. (2021). Smoking and immunotherapy efficacy in lung cancer by PDL1 subgroups: An individual participant data meta-analysis of atezolizumab clinical trials. European Journal of Cancer. 160. 279–281. 4 indexed citations

12.

Hu, Dong, Shashikanth Marri, Peter I. Mackenzie, et al.. (2021). The Expression Profiles and Deregulation of UDP-Glycosyltransferase (UGT) Genes in Human Cancers and Their Association with Clinical Outcomes. Cancers. 13(17). 4491–4491. 20 indexed citations

13.

Modi, Natansh D., Eugene Tan, Andrew Rowland, et al.. (2021). The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data. npj Breast Cancer. 7(1). 32 indexed citations

14.

Abuhelwa, Ahmad Y., Joaquim Bellmunt, Ganessan Kichenadasse, et al.. (2021). Enhanced Bellmunt Risk Score for Survival Prediction in Urothelial Carcinoma Treated With Immunotherapy. Clinical Genitourinary Cancer. 20(2). 132–138. 21 indexed citations

15.

Hu, Dong, Peter I. Mackenzie, Pramod C. Nair, Ross A. McKinnon, & Robyn Meech. (2020). The Expression Profiles of ADME Genes in Human Cancers and Their Associations with Clinical Outcomes. Cancers. 12(11). 3369–3369. 20 indexed citations

16.

Newman, Peter, et al.. (2019). Effectiveness of the Pharmacist-Involved Multidisciplinary Management of Heart Failure to Improve Hospitalizations and Mortality Rates in 4630 Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Cardiac Failure. 25(9). 744–756. 39 indexed citations

17.

Dyk, Madelé van, John O. Miners, Ganessan Kichenadasse, Ross A. McKinnon, & Andrew Rowland. (2016). A novel approach for the simultaneous quantification of 18 small molecule kinase inhibitors in human plasma: A platform for optimised KI dosing. Journal of Chromatography B. 1033-1034. 17–26. 12 indexed citations

18.

Nair, Pramod C., Robyn Meech, Peter I. Mackenzie, Ross A. McKinnon, & John O. Miners. (2015). Insights into the UDP-sugar selectivities of human UDP-glycosyltransferases (UGT): a molecular modeling perspective. Drug Metabolism Reviews. 47(3). 335–345. 25 indexed citations

19.

McKinnon, Ross A., et al.. (2005). Reduced arteriolar conducted vasoconstriction in septic mouse cremaster muscle is mediated by nNOS-derived NO. Cardiovascular Research. 69(1). 236–244. 44 indexed citations

20.

McKinnon, Ross A., et al.. (1995). Pharmacology and Drug Information for Nurses. eCite Digital Repository (University of Tasmania).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact